NDC 65293-005-00 - Cleviprex
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65293-005
- Requested NDC
- 65293-005-00
- Package NDCs from labels
- 65293-005-50, 65293-005-55, 65293-005-00, 65293-005-11, 65293-005-25, 65293-005-04
- Manufacturer
- The Medicines Company | Fresenius Kabi Austria Graz | Frescinius Kabi Austria Linz
- Effective date
- 2014-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cleviprex - The Medicines Company | Fresenius Kabi Austria Graz | Frescinius Kabi Austria Linz | The Medicines Company | Fresenius Kabi Austria Graz | Frescinius Kabi Austria Linz | 2014-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 65293-005-00 | ML - Milliliter | 65293-005 | 2e2e7f3c-3638-4f96-b2b1-0f505d133f5b | 1 | 2012-07-24 |
| 65293-005-11 | ML - Milliliter | 65293-005 | 958e16a4-d8a9-472f-9549-ffde7e0c978a | 1 | 2013-02-13 |
| 65293-005-50 | ML - Milliliter | 65293-005 | 24131298-04e5-44c3-8c57-1631a06cb93b | 1 | 2012-07-24 |
| 65293-005-55 | ML - Milliliter | 65293-005 | feedcc9d-309a-487e-b82d-79998bf28930 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CLEVIDIPINE | ACTIVE INGREDIENT | 19O2GP3B7Q | CLEVIPREX (CLEVIDIPINE) EMULSION [THE MEDICINES COMPANY] | 12 | |
| CLEVIDIPINE | ACTIVE MOIETY | 19O2GP3B7Q | CLEVIPREX (CLEVIDIPINE) EMULSION [THE MEDICINES COMPANY] | 12 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | CLEVIPREX (CLEVIDIPINE) EMULSION [THE MEDICINES COMPANY] | 12 | |
| EGG PHOSPHOLIPIDS | INACTIVE INGREDIENT | 1Z74184RGV | CLEVIPREX (CLEVIDIPINE) EMULSION [THE MEDICINES COMPANY] | 12 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | CLEVIPREX (CLEVIDIPINE) EMULSION [THE MEDICINES COMPANY] | 12 | |
| OLEIC ACID | INACTIVE INGREDIENT | 2UMI9U37CP | CLEVIPREX (CLEVIDIPINE) EMULSION [THE MEDICINES COMPANY] | 12 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CLEVIPREX (CLEVIDIPINE) EMULSION [THE MEDICINES COMPANY] | 12 | |
| SOYBEAN OIL | INACTIVE INGREDIENT | 241ATL177A | CLEVIPREX (CLEVIDIPINE) EMULSION [THE MEDICINES COMPANY] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona | FERULIC ACID, VITAMIN C, DMAE | ANUBIS COSMETICS SL | eaf0770c-795d-0232-e053-2a95a90ae0b5 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Vital Line | HYDROLYZED COLLAGEN | ANUBIS COSMETICS SL | f564bbf0-3b5c-4a81-e053-2a95a90a7ea6 | 2023-08-29 | Warnings | PDC6A3C0OX |
| Virility Liquescence | AVENA SATIVA, DAMIANA, BERBERIS VULGARIS, EPIMEDIUM GRANDIFLORUM, GLYCERINUM, SABAL SERRULATA, IODIUM, LECITHIN, FERRUM MURIATICUM, NATRUM MURIATICUM, AGNUS CASTUS, BUFO RANA, CINCHONA OFFICINALIS, HUMAN GROWTH HORMONE (HGH), ORCHITINUM (BOVINE), PHOSPHORICUM ACIDUM, PHOSPHORUS, SELENIUM METALLICUM, ZINCUM VALERIANICUM, OOPHORINUM (SUIS), SEPIA | Nutritional Specialties, Inc. | 81cc3e2b-f95e-4ba4-a15f-c07b4def0e2f | 2023-03-29 | Warnings | PDC6A3C0OX 1Z74184RGV |
| Metabolic Correction Blend | FOENICULUM VULGARE, AMMONIUM BROMATUM, FUCUS VESICULOSUS, LECITHIN (DERIVED FROM EGG), CAPSICUM ANNUUM, GALIUM APARINE, HYPOTHALAMUS SUIS, KALI BICHROMICUM, LAC DEFLORATUM (NSPC), PHYTOLACCA DECANDRA, PROGESTERONE, THYROIDINUM (BOVINE), PITUITARUM POSTERIUM (BOVINE), ANTIMONIUM CRUDUM, ARGENTUM METALLICUM, CALCAREA CARBONICA, FERRUM METALLICUM, GRAPHITES, ADRENALINUM, PHOSPHORUS | IHA Distribution, LLC | e8ec4f7e-c9dd-46dd-a9ee-2b8b7bcea9a8 | 2023-03-21 | Warnings | 1Z74184RGV |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | PDC6A3C0OX |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | PDC6A3C0OX |
| Cleviprex | CLEVIDIPINE | Fresenius Kabi Austria GmbH | a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330 | 2022-11-09 | Warnings, Adverse reactions | NDA022156 19O2GP3B7Q |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | PDC6A3C0OX |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | PDC6A3C0OX |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare CORP | 069460a5-3e9a-428f-b2dc-3405690f4fd7 | 2022-07-25 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | 55609586-f0b4-42e6-8dd9-cd090afb5dca | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | a69c82da-15ba-4d4d-8d7f-871dc3981eb8 | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I. V. FAT EMULSION | Baxter Healthcare Corporation | dd269651-30e8-43f0-880f-484346eaafeb | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX |
| Miracle FootCream Lavender | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db520c80-2a2a-5eb1-e053-2995a90a5bb4 | 2022-03-28 | Warnings | 7FLD91C86K PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.